{"id":202449,"date":"2026-03-27T19:07:29","date_gmt":"2026-03-27T19:07:29","guid":{"rendered":"https:\/\/www.europesays.com\/se\/202449\/"},"modified":"2026-03-27T19:07:29","modified_gmt":"2026-03-27T19:07:29","slug":"analytikern-tre-kopvarda-smabolag-placera-se","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/202449\/","title":{"rendered":"Analytikern: Tre k\u00f6pv\u00e4rda sm\u00e5bolag | Placera.se"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">I teknisk analys definieras sm\u00e5bolag ofta genom l\u00e5g oms\u00e4ttning, \u00e4ven om b\u00f6rsens segmentering bygger p\u00e5 b\u00f6rsv\u00e4rde. Handelsplattformen First North samlar fr\u00e4mst yngre, v\u00e4xande bolag med n\u00e5got l\u00e4gre krav \u00e4n huvudlistorna.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">F\u00f6r privata investerare kan aktier med l\u00e5g oms\u00e4ttning ge ett informations\u00f6vertag. St\u00f6rre institutioner har sv\u00e5rt att handla i dessa papper utan att p\u00e5verka kursen, och bevakningen fr\u00e5n analytiker \u00e4r ofta begr\u00e4nsad. Samtidigt inneb\u00e4r l\u00e5g likviditet en h\u00f6gre risk d\u00e5 det kan vara sv\u00e5rt att snabbt komma in eller ur positioner, vilket \u00f6kar volatiliteten och likviditetsrisken j\u00e4mf\u00f6rt med mer handlade aktier.<\/p>\n<p><img alt=\"Egtx\" loading=\"lazy\" decoding=\"async\" data-nimg=\"fill\" class=\"rounded-2xl max-w-full\" style=\"position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent\"   src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/03\/1774638448_425_image.jpeg\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Aktien till l\u00e4kemedelsbolaget <strong>Egetis Therapeutics <\/strong>uppvisar en huvudsakligen horisontell utveckling i grafen p\u00e5 medell\u00e5ng sikt. Den tekniska bilden har st\u00e4rkts ordentligt senaste m\u00e5naden efter att aktien brutit motst\u00e5ndet vid 5 kronor. Vidare har<a class=\"text-primary-90 hover:text-primary-110 underline hover:no-underline\" rel=\"noopener noreferrer nofollow\" target=\"_blank\" href=\"https:\/\/www.investtech.com\/se\/market.php?CountryID=46&amp;ref=azaart&amp;p=staticPage&amp;fn=helpResearchFormations#h_PatRecBuy\"> k\u00f6psignal fr\u00e5n rektangelformation<\/a> utl\u00f6sts. 6,10-6,60 kronor \u00e4r motst\u00e5ndsintervall \u2013 brott genom dessa niv\u00e5er skulle ge ny k\u00f6psignal och st\u00e4rkta tekniska utsikter f\u00f6r vidare uppg\u00e5ng. I dagsl\u00e4get f\u00e5r uppsidan anses begr\u00e4nsad mot bakgrund av n\u00e4rheten till motst\u00e5nden. 5 kronor \u00e4r st\u00f6d vid reaktion ned.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Egetis Therapeutics \u00e4r positiv p\u00e5 insiderhandel och samlat sett tekniskt positiv p\u00e5 en medell\u00e5ng investeringshorisont (1-6 m\u00e5nader).<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Investtechs rekommendation: K\u00f6p<\/p>\n<p><img alt=\"Eg7\" loading=\"lazy\" decoding=\"async\" data-nimg=\"fill\" class=\"rounded-2xl max-w-full\" style=\"position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent\"   src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/03\/1774638449_437_image.jpeg\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Spelbolaget <strong>Enad Global 7<\/strong> har handlats upp drygt 40 procent efter att ha bottnat intill 11 kronor i februari. Kursuppg\u00e5ngen har skett under allt h\u00f6gre handelsvolym vilket resulterat i en <a class=\"text-primary-90 hover:text-primary-110 underline hover:no-underline\" rel=\"noopener noreferrer nofollow\" target=\"_blank\" href=\"https:\/\/www.investtech.com\/se\/market.php?CountryID=46&amp;ref=azaart&amp;p=staticPage&amp;fn=helpResearchVolume#h_VbPos\">positiv volymbalans<\/a>. Aktien fick k\u00f6psignal efter att motst\u00e5ndet vid 14,60 kronor br\u00f6ts. Den positiva volymbalansen signalerar om gott k\u00f6pintresse bland investerarna och st\u00e4rker signalv\u00e4rdet. Motst\u00e5ndet vid 16 kronor i grafen p\u00e5 kort sikt testas. Brott genom detta skulle st\u00e4rka aktien. Motst\u00e5nd ovan denna niv\u00e5 runt 18 kronor. 14,60 kronor \u00e4r st\u00f6d.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">En maximalt positiv insiderhandel ger st\u00f6d till den tekniska bilden. Aktien \u00e4r totalt sett tekniskt positiv p\u00e5 en medell\u00e5ng investeringshorisont (1-6 m\u00e5nader).<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Investtechs rekommendation: K\u00f6p<\/p>\n<p><img alt=\"Borg\" loading=\"lazy\" decoding=\"async\" data-nimg=\"fill\" class=\"rounded-2xl max-w-full\" style=\"position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent\"   src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/03\/1774638449_89_image.jpeg\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Aktien till kl\u00e4df\u00f6retaget <strong>Bj\u00f6rn Borg<\/strong> utvecklas i en stigande trend p\u00e5 medell\u00e5ng sikt. Detta \u00e4r resultatet av att investerarna \u00f6ver tid handlat upp aktien till allt h\u00f6gre kurs. Efter en stark utveckling sedan i februari har motst\u00e5ndet vid 67 kronor brutits. K\u00f6psignal \u00e4r utl\u00f6st. Aktien st\u00e4ngde p\u00e5 alltime-high i torsdags (26\/3), vilket <a class=\"text-primary-90 hover:text-primary-110 underline hover:no-underline\" rel=\"noopener noreferrer nofollow\" target=\"_blank\" href=\"https:\/\/www.investtech.com\/se\/market.php?CountryID=46&amp;ref=azaart&amp;p=staticPage&amp;fn=helpResearchSupportAndResistance#h_Sup\">g\u00f6r att motst\u00e5nd saknas<\/a>. Detta \u00e4r positivt enligt Investtechs forskning och ger statistiskt goda m\u00f6jligheter till vidare kurskl\u00e4ttring. 67 kronor \u00e4r st\u00f6d.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Bj\u00f6rn Borg \u00e4r neutral i Investtechs insideranalys och tekniskt positiv p\u00e5 en medell\u00e5ng investeringshorisont (1-6 m\u00e5nader).<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Investtechs rekommendation: K\u00f6p<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Lars-G\u00f6ran Westerberg, analytiker Investtech<\/p>\n","protected":false},"excerpt":{"rendered":"I teknisk analys definieras sm\u00e5bolag ofta genom l\u00e5g oms\u00e4ttning, \u00e4ven om b\u00f6rsens segmentering bygger p\u00e5 b\u00f6rsv\u00e4rde. Handelsplattformen First&hellip;\n","protected":false},"author":2,"featured_media":202450,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[2696,22,23,10134,15234,26,27,17,21,24,25,28,29,15,16,18,34,31,33,32,30,6160,19,20],"class_list":{"0":"post-202449","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rubriker","8":"tag-bjorn-borg","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-egetis-therapeutics","12":"tag-enad-global-7","13":"tag-featured-news","14":"tag-featurednews","15":"tag-headlines","16":"tag-huvudnyheter","17":"tag-latest-news","18":"tag-latestnews","19":"tag-main-news","20":"tag-mainnews","21":"tag-news","22":"tag-nyheter","23":"tag-rubriker","24":"tag-se","25":"tag-svenska","26":"tag-sverige","27":"tag-sweden","28":"tag-swedish","29":"tag-teknisk-analys","30":"tag-top-stories","31":"tag-topstories"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116302711831710923","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/202449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=202449"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/202449\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/202450"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=202449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=202449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=202449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}